A Systematic Review of Intra-Articular Ketamine for Postoperative Analgesia.

Am J Phys Med Rehabil

From the Department of Physical Medical and Rehabilitation, Mayo Clinic, Rochester, Minnesota (SMC, WQ); Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota (RSD); and Department of Education Administration, Mayo Clinic, Rochester, Minnesota (PJE).

Published: November 2020

Background: This systematic review appraises the evidence from human clinical trials comparing postoperative pain scores and opioid consumption in patients receiving intra-articular ketamine versus other modalities of analgesia after orthopedic joint procedures.

Methods: Studies were identified from Embase, Scopus, and OVID Medline databases. Included studies compared patients receiving intra-articular ketamine versus other modalities of analgesia. The primary outcome of interest was postprocedural pain score and total opioid consumption, whereas secondary outcomes included time to rescue analgesic medication request, active range of motion, time to mobilization, and adverse effects.

Results: Seventeen studies were included. Dosage of ketamine varied widely from 0.25 to 2 mg/kg. Fifteen of 17 demonstrated decreased overall pain scores and decreased total postoperative opioid consumption in patients receiving intra-articular ketamine versus control groups. Included studies generally demonstrated reduced time to mobilization and increased latency until rescue analgesic medication in the intra-articular ketamine group.

Conclusions: Patients who received intra-articular ketamine generally reported lower pain scores and had lower postoperative opioid consumption after orthopedic joint procedures. This suggests that the intra-articular route of ketamine delivery may be a useful analgesic modality, although future larger-scale trials should explore its pharmacokinetics, optimal dosing, safety, and cost-effectiveness.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PHM.0000000000001483DOI Listing

Publication Analysis

Top Keywords

intra-articular ketamine
24
opioid consumption
16
pain scores
12
patients receiving
12
receiving intra-articular
12
ketamine versus
12
systematic review
8
ketamine
8
consumption patients
8
versus modalities
8

Similar Publications

Article Synopsis
  • - Juvenile idiopathic arthritis (JIA) encompasses various types of arthritis in children under 16, with treatments aiming to manage the disease, support growth, and improve quality of life using medications like NSAIDs and DMARDs.
  • - A study compared intraarticular corticosteroid injection (IACI) practices among pediatric rheumatologists in Turkey and India, gathering data through a questionnaire, which revealed that all clinicians used IACIs, mainly for oligoarticular JIA, with varying preferences in agents, techniques, and follow-up care.
  • - Despite the widespread use of IACIs, there are notable differences in practices and outcomes; thus, the authors suggest the need for standardized protocols through randomized studies to improve effectiveness and patient
View Article and Find Full Text PDF

Background: Previous studies have sought to determine the effect of inpatient ketamine therapy on postoperative pain in a variety of surgical specialties.

Purpose: To determine the effects of postoperative ketamine analgesia after periacetabular osteotomy (PAO) and/or derotational femoral osteotomy (DFO) on opioid requirements, pain, and discharge time.

Study Design: Cohort study; Level of evidence, 3.

View Article and Find Full Text PDF

The effect of low dose intra-articular S(+) ketamine on osteoarthritis in rats: an experimental study.

Braz J Anesthesiol

May 2024

Universidade Federal do Maranhão, Laboratório Experimental para Estudo da Dor, São Luiz, MA, Brazil; Universidade Federal do Maranhão, Departamento de Anestesiologia, Dor e Paliativos, São Luiz, MA, Brazil.

Background: This study aimed to investigate the analgesic impact of S(+)-ketamine on pain behavior and synovial inflammation in an osteoarthritis (OA) model.

Methods: Animals were grouped as follows: OA-Saline (n = 24) and OA-Ketamine (n = 24), OA induced via intra-articular sodium monoiodoacetate (MIA); a Non-OA group (n = 24) served as the control. On the 7 day post OA induction, animals received either saline or S(+)-ketamine (0.

View Article and Find Full Text PDF

Resveratrol nanocrystals based dissolving microneedles with highly efficient for rheumatoid arthritis.

Drug Deliv Transl Res

January 2025

Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs, School of Pharmacy, Yantai University, Yantai, 264005, PR China.

Rheumatoid arthritis (RA) is a common immune disease characterized mainly by erosive arthritis with extensive clinical sequelae. Resveratrol (Res) has pharmacological effects in the treatment of RA, but it has not been widely used in the clinic due to its poor water solubility and low bioavailability. In this study, a drug delivery system (Res-NC MNs) of dissolved microneedles (MNs) loaded with Res nanocrystals (NC) was designed for the treatment of RA.

View Article and Find Full Text PDF

Background: Optimal analgesic protocols for total knee arthroplasty (TKA) patients remain controversial. Multimodal analgesia is advocated, often including peripheral nerve blocks and/or periarticular injections (PAIs). If 2 blocks (adductor canal block [ACB] plus infiltration between the popliteal artery and capsule of the knee [IPACK]) are used, also performing PAI may not be necessary.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!